Published in Clin Infect Dis on April 22, 2002
Trichomoniasis. Clin Microbiol Rev (2004) 2.88
Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis (2009) 2.30
The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women. Sex Transm Infect (2011) 2.19
Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev (2009) 1.46
Trichomoniasis and HIV interactions: a review. Sex Transm Infect (2013) 1.36
Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. J Clin Microbiol (2006) 1.33
Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. Clin Infect Dis (2008) 1.31
Trichomonas vaginalis genital infections: progress and challenges. Clin Infect Dis (2011) 1.22
Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care. Sex Transm Dis (2012) 1.10
A Trich-y question: should Trichomonas vaginalis infection be reportable? Sex Transm Dis (2013) 1.02
Preconception and contraceptive care for women living with HIV. Infect Dis Obstet Gynecol (2012) 0.99
Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine. Parasitol Res (2010) 0.92
A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women. Sex Transm Dis (2013) 0.90
The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women. Sex Transm Dis (2011) 0.89
The Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the Literature. J Sex Transm Dis (2013) 0.83
Prevalence and predictors of trichomonas infection in newly incarcerated women. Sex Transm Dis (2012) 0.82
Prevalence and correlates of Trichomonas vaginalis infection among female US federal prison inmates. Sex Transm Dis (2010) 0.82
Mucosal immunity in the female genital tract, HIV/AIDS. Biomed Res Int (2014) 0.81
Trichomoniasis: the "neglected" sexually transmitted disease. Infect Dis Clin North Am (2013) 0.79
Prevalence and factors associated with Trichomonas vaginalis infection among high-risk women in Los Angeles. Sex Transm Dis (2013) 0.79
Genetic diversity of Trichomonas vaginalis reinfection in HIV-positive women. Sex Transm Infect (2013) 0.79
A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections. Clin Infect Dis (2015) 0.78
Trichomoniasis: An update. Trop Parasitol (2011) 0.78
Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the USA. Int J STD AIDS (2013) 0.78
Insight into trichomonas vaginalis genome evolution through metabolic pathways comparison. Bioinformation (2012) 0.76
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med (2010) 8.51
The prevention and treatment of missing data in clinical trials. N Engl J Med (2012) 6.92
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA (2010) 5.94
Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med (2009) 5.35
Pregnancy and infection. N Engl J Med (2014) 4.15
Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol (2007) 3.86
Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS (2006) 3.70
Publication bias in editorial decision making. JAMA (2002) 3.52
Fertility treatments and multiple births in the United States. N Engl J Med (2013) 3.45
A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS (2002) 3.41
Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS (2007) 3.22
An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity. Matern Child Health J (2007) 2.89
Rapid HIV-1 testing during labor: a multicenter study. JAMA (2004) 2.81
Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst (2003) 2.81
Pandemic influenza and pregnant women. Emerg Infect Dis (2008) 2.80
Integrating family planning and prevention of mother-to-child HIV transmission in resource-limited settings. Lancet (2005) 2.73
Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol (2010) 2.69
Tubal factor infertility and perinatal risk after assisted reproductive technology. Obstet Gynecol (2013) 2.66
The clonality of Staphylococcus aureus nasal carriage. J Infect Dis (2005) 2.39
Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS (2010) 2.33
Interim Guidelines for Pregnant Women During a Zika Virus Outbreak - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 2.27
Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2004) 2.17
Severe obstetric morbidity in the United States: 1998-2005. Obstet Gynecol (2009) 2.16
Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 2.15
Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr (2003) 2.11
Pandemic influenza and pregnant women: summary of a meeting of experts. Am J Public Health (2009) 2.09
The health of HIV-exposed children after early weaning. Matern Child Nutr (2011) 2.01
Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS (2007) 1.95
Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care (2010) 1.94
Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis (2006) 1.93
The acceptability of the female and male condom: a randomized crossover trial. Perspect Sex Reprod Health (2004) 1.90
Trends and outcomes for donor oocyte cycles in the United States, 2000-2010. JAMA (2013) 1.90
Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol (2006) 1.88
A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS (2007) 1.83
Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis (2001) 1.79
HIV seroprevalence among orphaned and homeless youth: no place like home. AIDS (2012) 1.76
Maternal mortality among Afghan refugees in Pakistan, 1999-2000. Lancet (2002) 1.74
Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis (2002) 1.73
Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis (2006) 1.72
Linkage to and engagement in HIV care in western Kenya: an observational study using population-based estimates from home-based counselling and testing. Lancet HIV (2015) 1.72
Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.71
Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis (2003) 1.70
2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol (2011) 1.69
Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA. Contraception (2013) 1.68
Assisted reproductive technology surveillance -- United States, 2010. MMWR Surveill Summ (2013) 1.64
Is there a trend of increased unwanted childbearing among young women in the United States? J Adolesc Health (2008) 1.63
Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis (2002) 1.63
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis (2003) 1.57
Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission. Clin Infect Dis (2012) 1.56
HIV seroprevalence in street youth, St. Petersburg, Russia. AIDS (2007) 1.56
Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.56
The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol (2009) 1.56
Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions. Am J Obstet Gynecol (2007) 1.55
A Randomized Trial of Human Papillomavirus Self-Sampling as an Intervention to Promote Cervical Cancer Screening Among Women With HIV. J Low Genit Tract Dis (2016) 1.54
Hospitalizations during pregnancy among managed care enrollees. Obstet Gynecol (2002) 1.50
States Monitoring Assisted Reproductive Technology (SMART) Collaborative: data collection, linkage, dissemination, and use. J Womens Health (Larchmt) (2013) 1.49
Assisted reproductive technology surveillance--United States, 2009. MMWR Surveill Summ (2012) 1.49
Health concerns of women and infants in times of natural disasters: lessons learned from Hurricane Katrina. Matern Child Health J (2007) 1.48
Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population. Obstet Gynecol (2015) 1.48
Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006. Obstet Gynecol (2010) 1.46
The use of community-based modified directly observed therapy for the treatment of HIV-infected persons. J Acquir Immune Defic Syndr (2005) 1.46
Safe conception for HIV-discordant couples: insemination with processed semen from the HIV-infected partner. Am J Obstet Gynecol (2013) 1.45
Low absolute neutrophil counts in african infants. J Int Assoc Physicians AIDS Care (Chic) (2005) 1.44
Interpreting the association between HIV and bone mineral density. AIDS (2007) 1.43
Continuity of medical care and risk of incarceration in HIV-positive and high-risk HIV-negative women. J Womens Health (Larchmt) (2002) 1.43
Infertility services reported by men in the United States: national survey data. Fertil Steril (2008) 1.42
Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States, July 2016. MMWR Morb Mortal Wkly Rep (2016) 1.41
Assessing the surgical and obstetrics-gynecology workload of medical officers: findings from 10 district hospitals in Ghana. Arch Surg (2012) 1.39
Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PLoS One (2011) 1.38
HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis (2011) 1.37
Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis (2007) 1.37
Principal stratification with predictors of compliance for randomized trials with 2 active treatments. Biostatistics (2007) 1.36
HIV-HBV coinfection--a global challenge. N Engl J Med (2012) 1.36
Ectopic pregnancy risk with assisted reproductive technology procedures. Obstet Gynecol (2006) 1.34
Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev (2007) 1.33
Effects of influenza on pregnant women and infants. Am J Obstet Gynecol (2012) 1.32
Differences between international recommendations on breastfeeding in the presence of HIV and the attitudes and counselling messages of health workers in Lilongwe, Malawi. Int Breastfeed J (2006) 1.32
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol (2010) 1.31
Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya. Addiction (2011) 1.29
Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994-2003. AIDS (2006) 1.29
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer (2006) 1.28
Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.28